A patient with severe persistent asthma, obesity, and COPD is experiencing an acute exacerbation characterized by respiratory acidosis and severe hypoxemia. The healthcare team is considering escalating to non-invasive ventilation. Which nursing intervention is the priority to prevent progression to respiratory failure?

D) Monitor for pneumothorax and adjust ventilation settings accordingly

A) Administer systemic corticosteroids to reduce airway inflammation

B) Increase diuretic dosage to manage elevated blood pressure

C) Initiate potassium supplementation to address potential hypokalemia

D) Monitor for pneumothorax and adjust ventilation settings accordingly

A 65-year-old female with severe persistent asthma and COPD presents with acute respiratory acidosis and severe hypoxemia. Her SpO2 is 89% on high-flow oxygen, and her arterial blood gases show pH 7.25, PaCO2 55 mmHg, PaO2 50 mmHg, and HCO3- 24 mEq/L. She is also hypertensive and has a history of diuretic use. Given these findings, what is the most appropriate initial nursing intervention to address her current respiratory status?

A) Initiate non-invasive positive pressure ventilation (NIPPV) to improve ventilation and oxygenation.

B) Administer intravenous diuretics to reduce pulmonary congestion.

C) Increase the flow rate of oxygen therapy to achieve SpO2 greater than 95%.

D) Start bronchodilator therapy and reassess in 30 minutes.

A patient with severe asthma exacerbation on non-invasive positive pressure ventilation (NIPPV) develops a right-sided pneumothorax. Considering the current clinical status, which nursing intervention is the priority to prevent further complications?

B) Assist with the insertion of a chest tube to decompress the pneumothorax.

A) Prepare for immediate intubation to secure the airway.

B) Assist with the insertion of a chest tube to decompress the pneumothorax.

C) Administer intravenous potassium replacement to correct hypokalemia.

D) Initiate systemic corticosteroids to reduce airway inflammation.

A patient with a severe asthma exacerbation on non-invasive positive pressure ventilation (NIPPV) develops acute chest pain and a right-sided pneumothorax, confirmed by ultrasound. The patient's trachea deviates to the left, and there are decreased breath sounds on the right. What is the priority nursing intervention to prevent cardiovascular collapse in this situation?

B) Prepare the patient for emergent chest tube insertion

A) Administer high-flow oxygen therapy immediately

B) Prepare the patient for emergent chest tube insertion

C) Initiate IV potassium replacement for hypokalemia

D) Increase the NIPPV settings to improve ventilation

After the insertion of the chest tube and initial stabilization of the patient's condition, the nurse is preparing to reassess the patient's respiratory status. Considering the patient's current clinical presentation and history of systemic corticosteroid use, which of the following interventions should the nurse prioritize to prevent further complications?

C) Assess for signs of adrenal insufficiency and prepare to administer additional corticosteroids if indicated.

A) Increase the flow of non-invasive positive pressure ventilation to improve oxygenation.

B) Monitor for signs of infection and initiate prophylactic antibiotic therapy immediately.

C) Assess for signs of adrenal insufficiency and prepare to administer additional corticosteroids if indicated.

D) Encourage the patient to take deep breaths and perform incentive spirometry to prevent atelectasis.

A patient with a moderate right-sided pneumothorax underwent chest tube insertion and showed improvement in SpO2 levels. However, her ABG analysis indicates persistent respiratory acidosis. As the nurse coordinating care, what should be the priority intervention to address the ongoing respiratory acidosis?

D) Collaborate with the healthcare team to titrate non-invasive ventilatory support

A) Increase the flow rate of high-flow oxygen therapy

B) Initiate invasive mechanical ventilation immediately

C) Reassess and adjust the position of the chest tube

D) Collaborate with the healthcare team to titrate non-invasive ventilatory support

A patient is experiencing worsening respiratory acidosis and new-onset atrial fibrillation following chest tube insertion. Which of the following interventions should the nurse prioritize to address the immediate respiratory and cardiac concerns?

C) Optimize oxygen delivery by ensuring proper function of high-flow oxygen therapy.

A) Initiate invasive mechanical ventilation immediately to address respiratory failure.

B) Administer IV beta-blockers to manage the atrial fibrillation and control heart rate.

C) Optimize oxygen delivery by ensuring proper function of high-flow oxygen therapy.

D) Begin broad-spectrum antibiotics to address the potential infection indicated by the low-grade fever.

A patient with a recently inserted chest tube is experiencing increased respiratory distress, worsening respiratory acidosis, and new-onset atrial fibrillation. Which of the following nursing interventions should be prioritized to address the patient's current clinical status?

B) Collaborate with the respiratory therapist to initiate BiPAP therapy while monitoring for potential hemodynamic instability.

A) Increase the oxygen flow rate to achieve a target SpO2 of 100%.

B) Collaborate with the respiratory therapist to initiate BiPAP therapy while monitoring for potential hemodynamic instability.

C) Administer a full dose of IV beta-blockers to rapidly control the heart rate.

D) Prepare to assist with immediate endotracheal intubation and mechanical ventilation.

A patient with atrial fibrillation, bronchospasm, and a confirmed Staphylococcus aureus bloodstream infection is experiencing worsening respiratory distress and hemodynamic instability. Despite high-flow oxygen, IV beta-blockers, and the initiation of an amiodarone infusion, the patient's SpO2 remains between 82-85%, and she exhibits tachypnea and stridor. Which of the following interventions should the nurse prioritize to stabilize the patient's condition?

B) Prepare for immediate endotracheal intubation and mechanical ventilation.

A) Increase the dose of the beta-blocker to better control the heart rate.

B) Prepare for immediate endotracheal intubation and mechanical ventilation.

C) Administer a bronchodilator to alleviate bronchospasm and improve oxygenation.

D) Initiate a vasopressor to stabilize the patient's fluctuating blood pressure.

A patient in the intensive care unit with a history of atrial fibrillation, respiratory distress, and a confirmed Staphylococcus aureus bloodstream infection is exhibiting signs of systemic inflammatory response syndrome (SIRS). After initiating amiodarone infusion and targeted antibiotic therapy, which nursing intervention is most critical to prioritize to ensure patient stability?

D) Prepare for intubation and mechanical ventilation if respiratory status worsens.

A) Increase IV fluid administration to prevent hypotension.

B) Monitor for signs of amiodarone toxicity, including QT prolongation.

C) Administer high-dose corticosteroids to control inflammation.

D) Prepare for intubation and mechanical ventilation if respiratory status worsens.

Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Asthma is characterized by chronic airway inflammation driven by an exaggerated Th2-mediated immune response, leading to increased production of cytokines such as IL-4, IL-5, and IL-13. This promotes eosinophilic infiltration and IgE synthesis, causing airway hyperreactivity to various triggers.

• Secondary mechanism: The inflammatory response results in bronchoconstriction due to increased smooth muscle contraction and airway edema. Additionally, goblet cell hyperplasia and subepithelial fibrosis occur, contributing to mucus hypersecretion and airway remodeling, which further obstruct airflow.

• Key complication: Severe asthma can lead to acute exacerbations, characterized by pronounced airway narrowing and gas trapping, possibly resulting in respiratory failure. This is due to the combination of extensive bronchoconstriction, mucus plugging, and compromised mucociliary clearance, necessitating urgent medical intervention to prevent hypoxemia and potential respira

Patient Profile

Demographics:

45-year-old female, factory worker

History:

• Key past medical history: Severe persistent asthma, chronic obstructive pulmonary disease (COPD), hypertension, and obesity

• Current medications: High-dose inhaled corticosteroids, long-acting beta-agonists, oral corticosteroids, antihypertensives, and a rescue inhaler (albuterol)

• Allergies: Penicillin, sulfites

Current Presentation:

• Chief complaint: Severe shortness of breath and wheezing

• Key symptoms: Persistent cough, chest tightness, difficulty breathing, fatigue, and anxiety

• Vital signs: Blood pressure 180/110 mmHg, heart rate 130 bpm, respiratory rate 34 breaths per minute, SpO2 82% on room air, temperature 37.8°C (100.0°F)

Section 1

New Diagnostic Results:

Following the initial presentation, the patient was promptly placed on high-flow oxygen therapy, elevating her SpO2 to 89%. Arterial blood gases were obtained, revealing a pH of 7.25, PaCO2 of 55 mmHg, PaO2 of 50 mmHg, and HCO3- of 24 mEq/L, indicative of acute respiratory acidosis with severe hypoxemia. A complete blood count showed elevated eosinophils at 8% (normal 1-4%), consistent with the eosinophilic inflammation characteristic of her severe persistent asthma. Chest X-ray results were unremarkable for pneumonia but revealed hyperinflation of the lungs, supporting the clinical picture of air trapping.

Spirometry could not be performed due to the patient's severe respiratory distress. An electrocardiogram (ECG) was conducted to assess her tachycardia and hypertension; it showed sinus tachycardia but no other acute ischemic changes. The patient's blood pressure remained elevated at 175/108 mmHg, and serum potassium was noted to be at the lower limit of normal at 3.5 mEq/L, a potential concern given her diuretic use for hypertension management. These diagnostic findings underscore the severity of the exacerbation and the complexity of her condition, necessitating a multi-faceted approach to management, including potential escalation to non-invasive ventilation and close monitoring for electrolyte imbalances or cardiac complications.

The healthcare team must now deliberate on the efficacy of current medical interventions and the potential need for systemic corticosteroids, considering her chronic corticosteroid use and the risk of adrenal insufficiency. The patient's obesity and COPD complicate the respiratory management plan, as her diaphragmatic mechanics are impaired, further challenging ventilatory support. The team must also anticipate and prevent potential complications such as pneumothorax from aggressive ventilation strategies or worsening hypokalemia, which could precipitate arrhythmias in the context of her elevated heart rate and blood pressure. The evolving scenario necessitates vigilant monitoring and dynamic adjustments in treatment to avert progression to respiratory failure.

Section 2

Change in Patient Status:

Despite the aggressive management approach, the patient's clinical status began to deteriorate rapidly. Over the next few hours, her respiratory distress intensified, with increasing use of accessory muscles and audible wheezing becoming more pronounced. Her SpO2 levels, despite high-flow oxygen, dropped further to 85%, indicating worsening hypoxemia. The patient reported severe dyspnea and her speech was limited to single words. Repeat arterial blood gas analysis showed a pH of 7.20, PaCO2 of 60 mmHg, and PaO2 of 45 mmHg, confirming worsening respiratory acidosis. These alarming trends suggested imminent respiratory failure, necessitating urgent reevaluation of her ventilatory support strategy.

In light of the deteriorating respiratory parameters, the healthcare team initiated non-invasive positive pressure ventilation (NIPPV) to alleviate the burden on her respiratory muscles and improve gas exchange. However, shortly after initiation, the patient developed acute chest pain and her blood pressure spiked to 185/115 mmHg. A bedside ultrasound was performed, revealing signs consistent with a right-sided pneumothorax, a recognized complication of positive pressure ventilation in severe asthma exacerbations. The patient's trachea was noted to be deviating to the left, and decreased breath sounds were auscultated on the right side. These findings necessitated immediate intervention to prevent cardiovascular collapse.

The emergent need for a chest tube insertion to decompress the pneumothorax was communicated to the on-call thoracic surgery team. Concurrently, electrolyte monitoring revealed a drop in serum potassium to 3.2 mEq/L, heightening the risk of arrhythmias, especially given her persistent tachycardia. The clinical team prepared an IV potassium replacement protocol while ensuring cardiac monitoring was intensified. These simultaneous challenges underscored the critical need for dynamic, multidisciplinary coordination to stabilize the patient's condition and avert further complications. As the team mobilized resources for the chest tube placement, they also initiated discussions on transitioning to systemic corticosteroids, weighing the risks of adrenal insufficiency against the need for potent anti-inflammatory action.

Section 3

As the thoracic surgery team prepared for the chest tube insertion, the patient’s condition remained precarious. Following the administration of IV potassium, her serum potassium levels showed a slight improvement to 3.5 mEq/L, yet her cardiac rhythm remained unstable with frequent premature ventricular contractions noted on the cardiac monitor. The team remained vigilant for signs of potential arrhythmias, aware that the combination of electrolyte imbalance, severe hypoxemia, and systemic corticosteroid initiation could exacerbate cardiac instability. Systemic corticosteroids were cautiously introduced with a bolus dose of methylprednisolone, with careful monitoring for any signs of adrenal insufficiency, especially given her acute stress state.

New diagnostic results from a repeat chest X-ray confirmed the presence of a moderate right-sided pneumothorax, which correlated with the clinical findings of decreased breath sounds and tracheal deviation. The pneumothorax was deemed sufficiently large to warrant urgent decompression. As the chest tube was inserted, the patient experienced significant relief from her acute chest pain, and her SpO2 levels showed a gradual improvement, rising to 90% with continued high-flow oxygen support. Her blood pressure began to stabilize, decreasing to 160/100 mmHg, as the immediate threat of cardiovascular compromise was mitigated.

Despite these improvements, the patient's respiratory effort remained labored, and her ABG analysis post-intervention revealed a persistent respiratory acidosis with a pH of 7.25, PaCO2 of 55 mmHg, and PaO2 of 55 mmHg. These results indicated an ongoing need for careful titration of non-invasive ventilatory support and potential escalation to invasive mechanical ventilation if her condition did not improve. The healthcare team remained on high alert, prepared to respond to further complications, including potential barotrauma from continued positive pressure ventilation or the development of secondary infections due to immunosuppression from corticosteroid therapy. The next steps in her treatment plan would require meticulous coordination and reassessment, ensuring that each intervention was adjusted in real-time to address her complex and evolving clinical picture.

Section 4

As the healthcare team continued to monitor the patient closely, a noticeable change in her status emerged. Approximately two hours after the chest tube insertion, during a routine assessment, the patient's respiratory effort became more pronounced, and her accessory muscle use increased significantly. Her SpO2, which had previously improved, began to decrease again, dropping to 85% despite high-flow oxygen support. This prompted an urgent reassessment of her respiratory status and a repeat ABG analysis. The results indicated a worsening respiratory acidosis, with a pH of 7.20, PaCO2 of 60 mmHg, and PaO2 of 50 mmHg, signaling that her respiratory function was deteriorating.

Simultaneously, the patient's heart rate increased to 130 beats per minute, with a noticeable irregularity on the monitor, suggesting the onset of an atrial fibrillation episode, likely precipitated by the combined stress of her respiratory instability and electrolyte disturbances. The team immediately initiated a protocol for managing acute atrial fibrillation, starting with the cautious administration of IV beta-blockers to control her heart rate while balancing the risk of further respiratory depression. Her blood pressure, which had previously stabilized, showed signs of fluctuation, indicating the need for close hemodynamic monitoring.

The patient’s clinical picture was further complicated by the appearance of a low-grade fever, 38.2°C (100.8°F), raising concerns for potential infection, possibly related to the chest tube insertion or secondary to her immunocompromised state from corticosteroid therapy. Blood cultures were drawn, and broad-spectrum antibiotics were initiated as a precautionary measure. The team recognized the critical need for a multidisciplinary approach, involving respiratory therapy to optimize ventilatory support, cardiology to manage her arrhythmia, and infectious disease specialists to address the risk of infection. This coordination was essential to stabilize the patient while preparing for potential escalation to invasive mechanical ventilation if her respiratory status continued to decline.

Section 5

As the team worked to stabilize the patient, her respiratory status continued to present significant challenges. Despite high-flow oxygen and the initiation of IV beta-blockers, her SpO2 remained stubbornly low, fluctuating between 82-85%. Her respiratory rate had increased further to 32 breaths per minute, and she exhibited pronounced wheezing and audible stridor, suggesting worsening bronchospasm. A repeat chest X-ray was ordered to rule out any complications from the chest tube or new developments such as pneumothorax or pneumonia. The imaging confirmed the correct placement of the chest tube but also revealed areas of atelectasis, likely contributing to her compromised gas exchange.

Meanwhile, the patient’s atrial fibrillation persisted with a heart rate now oscillating between 120-140 beats per minute, and her blood pressure showed further instability, with readings ranging from 90/60 mmHg to 140/90 mmHg. The beta-blockers had been adjusted cautiously to avoid exacerbating her respiratory compromise. However, this arrhythmia demanded more aggressive management, and after consulting with cardiology, the decision was made to initiate amiodarone infusion, carefully monitoring her hemodynamic response.

Compounding these issues, the patient’s blood cultures returned positive for Staphylococcus aureus, confirming a bloodstream infection likely secondary to the invasive procedures or her immunocompromised status. Her fever spiked to 39°C (102.2°F), and she began to show signs of systemic inflammatory response syndrome (SIRS), with a white blood cell count of 18,000/mm³ and elevated lactate levels at 4 mmol/L. The combination of respiratory distress, cardiac instability, and infection posed a critical threat, necessitating the escalation to the intensive care unit for potential mechanical ventilation and more aggressive sepsis management, including targeted antibiotic therapy and fluid resuscitation to support her rapidly fluctuating blood pressure.